Trial Profile
NovoMix FlexPen, Post Marketing Surveillance Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2016
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Novo Nordisk
- 29 Feb 2012 New trial record